诚意药业
(603811)
| 流通市值：29.85亿 | | | 总市值：29.85亿 |
| 流通股本：3.27亿 | | | 总股本：3.27亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 172,683,012.67 | 173,037,913.66 | 207,905,352.47 | 177,180,581.95 |
| 应收票据及应收账款 | 39,679,124.7 | 32,959,369.27 | 37,047,632.83 | 65,003,913.97 |
| 其中：应收票据 | - | 50,000 | - | - |
| 应收账款 | 39,679,124.7 | 32,909,369.27 | 37,047,632.83 | 65,003,913.97 |
| 应收款项融资 | 9,979,727 | 39,952,790.52 | 69,725,341.37 | 33,629,524.49 |
| 预付款项 | 8,841,183.55 | 8,610,753.26 | 8,017,767.13 | 9,323,892.85 |
| 其他应收款合计 | 4,043,601.69 | 6,471,053.08 | 3,182,673.68 | 11,467,653.05 |
| 应收股利 | - | - | - | 9,000,400 |
| 存货 | 118,406,392.38 | 131,843,548.31 | 126,496,453.93 | 126,133,142.89 |
| 其他流动资产 | 234,442.54 | 523,476.2 | 266,524.5 | 322,630.34 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 354,092,275.8 | 393,623,695.57 | 475,859,475.06 | 447,690,729.13 |
| 非流动资产: | | | | |
| 长期股权投资 | 324,362,009.21 | 314,867,199.27 | 303,199,753.7 | 292,080,574.08 |
| 投资性房地产 | 960,707.5 | 990,732.97 | 1,020,758.44 | 1,050,783.91 |
| 固定资产 | 921,605,278.77 | 940,521,058.01 | 922,619,941.3 | 944,007,204.43 |
| 在建工程 | 7,103,661.08 | 5,149,260.06 | 7,650,137.77 | 4,229,942.42 |
| 使用权资产 | - | 16,491.34 | 703,372.76 | 876,051.8 |
| 无形资产 | 63,340,157.59 | 63,949,594.93 | 74,986,887.59 | 75,905,718.64 |
| 长期待摊费用 | 352,973.02 | 406,342.06 | 948,491.71 | 1,109,190.91 |
| 递延所得税资产 | 4,938,144.63 | 6,298,303 | 5,110,243 | 5,601,188.17 |
| 其他非流动资产 | 3,431,207.31 | 2,558,072.65 | 25,300,196.45 | 24,478,344.14 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,326,094,139.11 | 1,334,757,054.29 | 1,341,539,782.72 | 1,349,338,998.5 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,680,186,414.91 | 1,728,380,749.86 | 1,817,399,257.78 | 1,797,029,727.63 |
| 流动负债: | | | | |
| 短期借款 | 50,095,500 | 51,100,780.56 | 52,846,355.56 | 62,849,625.56 |
| 应付票据及应付账款 | 51,957,453.39 | 84,669,674.42 | 75,537,044.78 | 74,491,090.63 |
| 其中：应付票据 | 1,017,200 | - | - | - |
| 应付账款 | 50,940,253.39 | 84,669,674.42 | 75,537,044.78 | 74,491,090.63 |
| 合同负债 | 9,167,755.33 | 12,221,076.33 | 61,081,522.53 | 5,261,849.59 |
| 应付职工薪酬 | 17,446,472.85 | 23,285,902.83 | 12,792,194.44 | 11,233,338.62 |
| 应交税费 | 17,621,650.06 | 21,317,672.24 | 16,469,894.36 | 19,549,652.9 |
| 其他应付款合计 | 53,628,865.75 | 56,906,664.36 | 56,438,165.3 | 58,005,052.67 |
| 一年内到期的非流动负债 | 25,199,650.92 | 40,448,699.69 | 68,873,580.3 | 224,621,699.82 |
| 其他流动负债 | 1,167,640.88 | 1,553,250.04 | 929,910.36 | 664,856.43 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 226,284,989.18 | 291,503,720.47 | 344,968,667.63 | 456,677,166.22 |
| 非流动负债: | | | | |
| 长期借款 | 118,508,000 | 139,308,000 | 189,583,248.46 | 96,849,962.5 |
| 租赁负债 | - | - | 418,918.82 | 478,350.18 |
| 递延收益 | 17,986,187.47 | 18,766,750.48 | 20,094,595.95 | 20,783,100.1 |
| 递延所得税负债 | 13,327,521.18 | 13,735,975.95 | 14,144,430.71 | 14,552,885.47 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 149,821,708.65 | 171,810,726.43 | 224,241,193.94 | 132,664,298.25 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 376,106,697.83 | 463,314,446.9 | 569,209,861.57 | 589,341,464.47 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 327,304,320 | 327,304,320 | 327,304,320 | 327,304,320 |
| 资本公积 | 142,998,487.16 | 142,998,487.16 | 142,998,487.16 | 142,998,487.16 |
| 减:库存股 | 75,118,432.64 | 67,263,133.8 | - | - |
| 其他综合收益 | - | - | 232,768.19 | 225,720.53 |
| 盈余公积 | 138,586,838.77 | 138,586,838.77 | 119,522,219.98 | 119,522,219.98 |
| 未分配利润 | 764,251,145.9 | 718,457,975.29 | 653,895,394.23 | 613,287,320.63 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,298,022,359.19 | 1,260,084,487.42 | 1,243,953,189.56 | 1,203,338,068.3 |
| 少数股东权益 | 6,057,357.89 | 4,981,815.54 | 4,236,206.65 | 4,350,194.86 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,304,079,717.08 | 1,265,066,302.96 | 1,248,189,396.21 | 1,207,688,263.16 |
| 负债和股东权益合计 | 1,680,186,414.91 | 1,728,380,749.86 | 1,817,399,257.78 | 1,797,029,727.63 |
| 公告日期 | 2025-04-30 | 2025-04-30 | 2024-10-29 | 2024-08-21 |
| 审计意见(境内) | | 标准无保留意见 | | |